Drug Combination Details
General Information of the Combination (ID: C47170) | |||||
---|---|---|---|---|---|
Name | Luteolin NP Info | + | Imatinib Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Chronic myelogenous leukaemia
[ICD-11: 2A20]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
In-vitro Model | K-562 | CVCL_0004 | Chronic myelogenous leukemia | Homo sapiens | ||
Experimental
Result(s) |
Combination treatment may provide better outcomes in terms of cytotoxicity and thus reduce the dosages of imatinib used. |
